Source: ALL
Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 2875
Gene Symbol: GPT
GPT
0.100 Biomarker disease BEFREE ALT and ultrasound have mediocre accuracy in detecting steatosis in children with obesity. 30903305 2019
Entrez Id: 3458
Gene Symbol: IFNG
IFNG
0.300 Biomarker disease RGD [Effects of leptin on airway inflammation and the expression of Th1/Th2 cytokines in asthmatic rats]. 19575934 2009
Entrez Id: 3952
Gene Symbol: LEP
LEP
0.700 Biomarker disease BEFREE Zucker (fa/fa) rats with defective leptin receptors are obese, hyperphagic, and hyperinsulinemic. 12882910 2003
Entrez Id: 125919
Gene Symbol: ZNF543
ZNF543
0.010 Biomarker disease BEFREE ZNF397OS and ZNF543 represented the top scoring associated events that were further validated in an independent cohort and exhibited strong correlation with BMI and excellent and statistically significant efficiency in the discrimination of obese from non-obese CRC patients (area under the curve >0.80; p < 0.05). 29717273 2019
Entrez Id: 3952
Gene Symbol: LEP
LEP
0.700 Biomarker disease BEFREE Zebrafish Mutants Carrying Leptin a (lepa) Gene Deficiency Display Obesity, Anxiety, Less Aggression and Fear, and Circadian Rhythm and Color Preference Dysregulation. 30551684 2018
Entrez Id: 3953
Gene Symbol: LEPR
LEPR
0.700 GeneticVariation disease BEFREE Young male Zucker rats with a leptin receptor mutation are obese, have a non-insulin-dependent diabetes mellitus (NIDDM), and other endocrinopathies. 30339059 2018
Entrez Id: 278
Gene Symbol: AMY1C
AMY1C
0.100 AlteredExpression disease BEFREE Yet, we also found a significant negative contribution of AMY1 activity at baseline to the change in BMI during the 9-year follow-up, and a significant contribution of AMY1A copy number to lower obesity risk in children, suggesting a bidirectional relationship between AMY1 activity and adiposity. 28228143 2017
Entrez Id: 26292
Gene Symbol: MYCBP
MYCBP
0.100 AlteredExpression disease BEFREE Yet, we also found a significant negative contribution of AMY1 activity at baseline to the change in BMI during the 9-year follow-up, and a significant contribution of AMY1A copy number to lower obesity risk in children, suggesting a bidirectional relationship between AMY1 activity and adiposity. 28228143 2017
Entrez Id: 277
Gene Symbol: AMY1B
AMY1B
0.100 AlteredExpression disease BEFREE Yet, we also found a significant negative contribution of AMY1 activity at baseline to the change in BMI during the 9-year follow-up, and a significant contribution of AMY1A copy number to lower obesity risk in children, suggesting a bidirectional relationship between AMY1 activity and adiposity. 28228143 2017
Entrez Id: 4780
Gene Symbol: NFE2L2
NFE2L2
0.100 Biomarker disease BEFREE Working to understand the complex interplay among Nrf2, oxidative stress, and adipose biology could lead to a variety of possible treatments for obesity and other related disorders. 23319124 2013
Entrez Id: 2688
Gene Symbol: GH1
GH1
0.400 GeneticVariation disease BEFREE Work on the GH receptor (R)-knockout (GHRKO) mice and results of studies on GH-resistant Laron Syndrome (LS) patients have helped define many physiological actions of GH including those dealing with metabolism, obesity, cancer, diabetes, cognition and aging/longevity. 29459441 2018
Entrez Id: 2690
Gene Symbol: GHR
GHR
0.100 Biomarker disease BEFREE Work on the GH receptor (R)-knockout (GHRKO) mice and results of studies on GH-resistant Laron Syndrome (LS) patients have helped define many physiological actions of GH including those dealing with metabolism, obesity, cancer, diabetes, cognition and aging/longevity. 29459441 2018
Entrez Id: 1401
Gene Symbol: CRP
CRP
0.600 Biomarker disease BEFREE Women, blacks, Hispanics, and socioeconomically disadvantaged groups had higher risks of obesity and elevated C-reactive protein, with the SES gradients being more pronounced in female participants. 28818242 2017
Entrez Id: 23212
Gene Symbol: RRS1
RRS1
0.020 Biomarker disease BEFREE Women with primary (RRR 1.91, 95% CI: 1.36-2.67), secondary education (RRR 1.42, 95% CI 1.00, 2.01) were at increased risk of overweight/obesity. 31075139 2019
Entrez Id: 57104
Gene Symbol: PNPLA2
PNPLA2
0.100 AlteredExpression disease BEFREE Women with PCOS or obesity had significantly decreased norepinephrine-induced lipolysis and HSL protein expression but no change in ATGL protein expression. 17327373 2007
Entrez Id: 3991
Gene Symbol: LIPE
LIPE
0.300 AlteredExpression disease BEFREE Women with PCOS or obesity had significantly decreased norepinephrine-induced lipolysis and HSL protein expression but no change in ATGL protein expression. 17327373 2007
Entrez Id: 4160
Gene Symbol: MC4R
MC4R
1.000 GeneticVariation disease BEFREE Women with extreme obesity carrying rs17782313 MC4R polymorphism present a higher pre-surgical BMI, are more unlikely to reach non-obesity BMI (<30 kg/m<sup>2</sup>) and tend to maintain a BMI > 35 kg/m<sup>2</sup> that characterize treatment failure. 28579220 2018
Entrez Id: 3953
Gene Symbol: LEPR
LEPR
0.700 AlteredExpression disease BEFREE Women with DS exhibited lower total leptin concentrations (P<.01), comparable leptin receptor level and, therefore, lower free leptin values (P<.01) when compared with obese controls, then resembling the profile peculiar to normal-weight control women. 17618952 2007
Entrez Id: 6046
Gene Symbol: BRD2
BRD2
0.060 Biomarker disease BEFREE Women with obesity usually need larger doses of FSH for ovarian stimulation, resulting in poor outcomes; however, the mechanism is still unclear. 30476103 2019
Entrez Id: 1499
Gene Symbol: CTNNB1
CTNNB1
0.170 Biomarker disease BEFREE Wnt/β-Catenin Signaling and Obesity. 30065654 2018
Entrez Id: 3952
Gene Symbol: LEP
LEP
0.700 Biomarker disease BEFREE WNIN/Ob is leptin resistant with unaltered leptin or its receptor coding sequences--the two well-known candidate genes for obesity. 24204914 2013
Entrez Id: 51141
Gene Symbol: INSIG2
INSIG2
0.100 GeneticVariation disease BEFREE Within the DPP study population, common variants in FTO and INSIG2 are nominally associated with quantitative measures of obesity, directly and possibly by interacting with metformin or lifestyle intervention. 18839134 2008
Entrez Id: 9370
Gene Symbol: ADIPOQ
ADIPOQ
0.600 AlteredExpression disease BEFREE Within MZ twin pairs, acquired obesity was significantly related to increased adipocyte size and increased adipose tissue mRNA expressions of leptin, TNFalpha and the macrophage marker CD68, and decreased mRNA expressions of adiponectin and peroxisome proliferator-activated receptor-gamma. 16608891 2006
Entrez Id: 3952
Gene Symbol: LEP
LEP
0.700 AlteredExpression disease BEFREE Within MZ twin pairs, acquired obesity was significantly related to increased adipocyte size and increased adipose tissue mRNA expressions of leptin, TNFalpha and the macrophage marker CD68, and decreased mRNA expressions of adiponectin and peroxisome proliferator-activated receptor-gamma. 16608891 2006
Entrez Id: 5327
Gene Symbol: PLAT
PLAT
0.020 Biomarker disease BEFREE With the growth of obesity in the United States and the lack of data supporting dose capping of alteplase, it remains unclear if this dosing practice should continue to be accepted without question. 28129994 2017